Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
1.55M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
591K
-
Shares change
-
+359K
-
Total reported value, excl. options
-
$2.94M
-
Value change
-
+$1.81M
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$4.97
Significant Holders of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) as of Q3 2025
17 filings reported holding EVOK - Evoke Pharma Inc - Common Stock, par value $0.0001 per share as of Q3 2025.
Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 591K shares
of 1.55M outstanding shares and own 38.05% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (159K shares), Nantahala Capital Management, LLC (148K shares), Bleichroeder LP (146K shares), National Wealth Management Group, LLC (80.1K shares), DRW Securities, LLC (23.7K shares), VANGUARD GROUP INC (18.8K shares), TWO SIGMA SECURITIES, LLC (10.4K shares), OSAIC HOLDINGS, INC. (3.01K shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (272 shares), and ROYAL BANK OF CANADA (190 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.